EYE DISORDERS CONGENITAL
Clinical trials for EYE DISORDERS CONGENITAL explained in plain language.
Never miss a new study
Get alerted when new EYE DISORDERS CONGENITAL trials appear
Sign up with your email to follow new studies for EYE DISORDERS CONGENITAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental eye drug hopes to restore sight in rare blindness
Disease control Recruiting nowThis phase 3 trial tests an experimental drug called sepofarsen in 32 people with Leber congenital amaurosis (LCA), a rare genetic condition that causes severe vision loss from birth. The drug is injected into one eye, while the other eye gets a placebo, to see if it safely impro…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE3 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New eye injection aims to slow blindness in rare genetic disease
Disease control Recruiting nowThis study tests an experimental drug called ultevursen for people with retinitis pigmentosa caused by a specific gene mutation (USH2A). The drug is injected into the eye and may help slow vision loss. The trial involves 81 participants, some of whom will receive a sham (fake) in…
Matched conditions: EYE DISORDERS CONGENITAL
Phase: PHASE2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC